Kintara Therapeutics (KTRA) Lights Up With FDA Approval

$Kintara Therapeutics, Inc.(KTRA)$ 

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The Company operates within a single operating segment the research and development of cancer indications, and operates primarily in one geographic area, being North America.

# Q3 Earnings Analysis

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment17

  • Top
  • Latest
  • LeongSS
    ·2022-12-03
    thanks for sharing
    Reply
    Report
  • 700k
    ·2022-12-03
    Sold before the weekend !
    Reply
    Report
  • aiyoh79
    ·2022-12-03
    Ok
    Reply
    Report
  • Sharon17
    ·2022-12-03
    Haode
    Reply
    Report
  • Burger King
    ·2022-12-03
    🍀
    Reply
    Report
  • Dennis1015
    ·2022-12-03
    ok
    Reply
    Report
  • Smallbee
    ·2022-12-03
    Ok
    Reply
    Report
  • OAHI3W
    ·2022-12-03
    👍
    Reply
    Report
  • stsockli
    ·2022-12-03
    good
    Reply
    Report
  • ValuInvestor
    ·2022-12-03
    Ok
    Reply
    Report
  • CloudLoo
    ·2022-12-03
    👍
    Reply
    Report
  • Skinbanana
    ·2022-12-03
    👍
    Reply
    Report
  • T202311701
    ·2022-12-03
    Reply
    Report
  • Dodonan
    ·2022-12-03
    K
    Reply
    Report
  • IcyAlchemist
    ·2022-12-03
    Ok
    Reply
    Report
  • Wong888888
    ·2022-12-03
    thanks
    Reply
    Report
  • andy_jap
    ·2022-12-03
    ok
    Reply
    Report